期刊文献+

雷诺嗪消旋体及其光学异构体的药动学研究

Study on the Pharmacokinetics of Ranolazine and Its Optical Isomer
原文传递
导出
摘要 目的研究雷诺嗪消旋体及其光学异构体在大鼠体内的药动学特点。方法采用高效液相色谱法测定给药后不同时间点大鼠血浆中雷诺嗪消旋体及其光学异构体的含量,并计算药动学参数。结果主要药动学参数如下:雷诺嗪消旋体低、中、高剂量的Cmax分别为(3.404±0.442),(5.858±0.422)和(8.186±0.625)mg·L?1;Tmax分别为(0.250±0.000),(0.250±0.000)和(0.500±0.000)h;AUC0-12 h分别为(7.033±0.757),(13.055±1.665)和(20.899±2.965)mg·h·L?1;t1/2分别为(4.882±2.017),(6.757±2.932)和(4.603±0.462)h;R-雷诺嗪低、中、高剂量的Cmax分别为(1.144±0.193),(3.999±0.830)和(5.987±0.321)mg·L?1;Tmax分别为(0.500±0.000),(0.583±0.144)和(0.477±0.632)h;AUC0-12 h分别为(4.182±0.555),(8.831±1.092)和(13.517±7.238)mg·h·L?1;t1/2分别为(4.420±0.694),(3.430±0.773)和(4.221±2.881)h;S-雷诺嗪低、中、高剂量的Cmax分别为(0.756±0.227),(2.786±0.269)和(4.769±0.501)mg·L?1;Tmax分别为(0.583±0.144),(0.500±0.000)和(0.417±0.144)h;AUC0-12 h分别为(3.696±0.821),(6.695±0.888)和(9.976±0.314)mg·h·L?1;t1/2分别为(3.191±0.322),(5.630±1.086)和(4.603±0.462)h。结论统计学结果表明,R-雷诺嗪和S-雷诺嗪的Cmax、Tmax、t1/2、AUC0-12 h均无显著性差异,雷诺嗪消旋体与不同光学异构体相比在体内有较好的吸收。 OBJECTIVE To study the pharmacokinetics of ranolazine and its optical isomers in rat plasma. METHODS The concentrations of ranolazine in rats plasma at different time were determined by HPLC and the pharmacokinetic parameters were calculated. RESULTS The pharmacokinetic parmeters were as follows: the group of ranolazine: Cmax(3.404±0.442),(5.858±0.422) and(8.186±0.625)mg·L^-1; Tmax(0.250±0.000),(0.250±0.000) and(0.500±0.000)h; AUC0-12 h(7.033±0.757),(13.055±1.665) and(20.899±2.965)mg·h·L^-1; T1/2(4.882±2.017),(6.757±2.932) and(4.603±0.462)h; the group of R-ranolazine: Cmax(1.144±0.193),(3.999±0.830) and(5.987±0.321)mg·L^-1; Tmax(0.500±0.000),(0.583±0.144) and(0.477±0.632)h; AUC0-12 h(4.182±0.555),(8.831±1.092) and(13.517±7.238)mg·h·L^-1; T1/2(4.420±0.694),(3.430±0.773) and(4.221±2.881)h, the group of S-ranolazine Cmax(0.756±0.227),(2.786±0.269) and(4.769±0.501)mg·L^-1; Tmax(0.583±0.144),(0.500±0.000) and(0.417±0.144)h; AUC0-12 h(3.696±0.821),(6.695±0.888) and(9.976±0.314)mg·h·L^-1; T1/2(3.191±0.322),(5.630±1.086) and(4.603±0.462)h. CONCLUSION Statistical results show that the value of Cmax, Tmax, T1/2 and AUC of R-Ranolazine and S-Ranolazine has no significant difference. Ranolazine compared with different optical isomer has good absorption in the body.
出处 《中国现代应用药学》 CAS CSCD 2014年第11期1366-1370,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 雷诺嗪 光学异构体 药动学 高效液相色谱法 ranolazine optical isomers pharmacokinetic HPLC
  • 相关文献

参考文献5

  • 1STANLEY W C. Ranolazine: new approach for the treatmentof stable angina pec-toris [J]. Expert Rev Cardiovasc Ther2005,3(5): 821-829.
  • 2BHAUMIK U, GHOSH A, SARKAR A K, et al.Determination of ranolazine in human plasma by LC-MS/MSand its application in bioequivalence study [J]. Pharm BiomedAanl, 2008, 48(5): 1404-1410.
  • 3REN P. Pharmacokinetics and toxicokinetics of ranolzaine[D]. Shandong University(山东大学),2007.
  • 4胡凯,扈荣,许鹏庆,白海波,傅旭春.落新妇苷固体分散体在大鼠体内的药动学研究[J].中国现代应用药学,2013,30(10):1102-1104. 被引量:4
  • 5叶亚琳,李雪,徐江平,杨雪梅.雷诺嗪的大鼠体内药物动力学研究[J].中国医药工业杂志,2006,37(7):478-480. 被引量:7

二级参考文献5

  • 1Timmis AD,Chaitman B R,Crager M.Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes[J].Eur Heart J,2006,27 (1):42-48.
  • 2Antzelevitch C,Belardinelli L,Zygmunt AC,et al.Electrophysiological effects of ranolazine,a novel antianginal agent with antiarrhythmic properties[J].Circulation,2004,110 (8):904-910.
  • 3Liu XD,Xie L,Liang Y,et al.Gender difference in ranolazine pharmacokinetics in rats[J].Eur J Drug Metab Pharmacokinet,2003,28 (2):119-123.
  • 4韩刚,阎林奇,索炜,王成强,刘莉,赵媛.大黄素固体分散体的制备及其溶出度测定[J].中草药,2011,42(3):487-490. 被引量:33
  • 5金卫坤,陈幼亭,邹建华,顾继红.苯妥英钠C-T曲线的双峰现象[J].中国临床药学杂志,1997,6(2):62-63. 被引量:1

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部